Showing posts with label vaccine. Show all posts
Showing posts with label vaccine. Show all posts

Galvez: Covid-19 vaccines in the first quarter this year would not be enough to cover health workers, frontliners and senior citizens

Vaccine czar Carlito Galvez admitted during the cabinet meeting last night that the initial shipment of 5.1 million doses of Covid-19 vaccines in the first quarter this year would not be enough:
  • Only 3.5 million doses of vaccines from Covax facility (Pfizer and AstraZeneca);
  • 600,000 doses of Sinovac donated by the Chinese government (which may arrive this week); and
  • One million doses of AstraZeneca vaccine procured by the Department of Health (DOH).


 

WHO: Wealthy Nations Must Share Vaccine Doses With Poor Countries; The Goal of Equitable Distribution in Jeopardy

 


WHO Director-General Tedros Adhanom Ghebreyesus urged wealthy nations to share vaccine doses with COVAX, saying the goal of equitable distribution was “in jeopardy”.

“So far 210 million doses of vaccine have been administered globally but half of those are in just two countries,” Tedros said in Geneva. “More than 200 countries are yet to administer a single dose.”

COVAX is co-led by the WHO, the GAVI vaccines alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and UNICEF.

It was launched in June 2020 to try to prevent poorer countries being pushed to the back of the queue for COVID-19 vaccines as wealthier nations bought up billions of doses for their populations.

Philippine FDA: CoronaVac' Efficacy Rate is Only 50.4%, Not Fit For Health Workers Nor Senior Citizens

The Philippine Food and Drug Administration (FDA) has granted CoronaVac, the Covid-19 vaccine of China's Sinovac, an emergency use authorization (EUA) today.

But the FDA said that CoronaVac's efficacy rate is only 50.4 percent. 

FDA said it was not fit for health workers who are always exposed to Covid-19 patients nor for senior citizens who have comorbidities.

FDA also said that the Sinovac vaccine should only be administered to clinically healthy individuals aged 18 to 59 years old.